Skip to content
Facebook Instagram Linkedin

LifeScienceHistory.com

History made daily

  • Home
  • DirectoryExpand
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • News and History
  • Cartoons
  • Small World
  • Earth is a RockExpand
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
LifeScienceHistory.com
History made daily
Home / Therapeutics - Page 70

Therapeutics

The University of Minnesota Masonic Children’s Hospital opened a new, innovative building for mothers and children
Biotechnology | Diagnostics | Disease | Medicine | Non-Profit Research | Therapeutics | Women's Health

The University of Minnesota Masonic Children’s Hospital opened a new, innovative building for mothers and children

On Apr. 30, 2011, The University of Minnesota Masonic Children’s Hospital opened a new, innovative building for mothers…

Read More The University of Minnesota Masonic Children’s Hospital opened a new, innovative building for mothers and childrenContinue

Governor Mary Fallin dedicated OMRF’s new 186,000 square foot research tower
Biotechnology | Medicine | Non-Profit Research | Therapeutics

Governor Mary Fallin dedicated OMRF’s new 186,000 square foot research tower

On Apr. 21, 2011, Governor Mary Fallin dedicated the Oklahoma Medical Research Foundation’s (OMRF) new 186,000 s.f. research…

Read More Governor Mary Fallin dedicated OMRF’s new 186,000 square foot research towerContinue

Jon M and Karen Huntsman donated $41 million to cancer research at Huntsman Cancer Institute
Biotechnology | Diagnostics | Disease | Non-Profit Research | Oncology | Radiology | Therapeutics

Jon M and Karen Huntsman donated $41 million to cancer research at Huntsman Cancer Institute

On Apr. 21, 2011, Jon M. and Karen Huntsman donated $41 million to cancer research at Huntsman Cancer…

Read More Jon M and Karen Huntsman donated $41 million to cancer research at Huntsman Cancer InstituteContinue

Siemens introduced Aquaris, the world’s first waterproof, dust proof, and shock-resistant digital hearing aid
Medical Device | Therapeutics

Siemens introduced Aquaris, the world’s first waterproof, dust proof, and shock-resistant digital hearing aid

On Apr. 5, 2011, Siemens, now Sivantos, introduced Aquaris, the world’s first waterproof, dust proof, and shock-resistant digital…

Read More Siemens introduced Aquaris, the world’s first waterproof, dust proof, and shock-resistant digital hearing aidContinue

OMRF’s Multiple Sclerosis Center of Excellence opened its doors
Biotechnology | Disease | Therapeutics

OMRF’s Multiple Sclerosis Center of Excellence opened its doors

On Mar. 15, 2011, the Oklahoma Medical Research Foundation’s Multiple Sclerosis Center of Excellence, led by Dr. Gabriel…

Read More OMRF’s Multiple Sclerosis Center of Excellence opened its doorsContinue

Gilead Sciences acquired Calistoga Pharmaceuticals for $375 Million
Biotechnology | FDA | Life Science History | Oncology | Pharmaceutical | Therapeutics

Gilead Sciences acquired Calistoga Pharmaceuticals for $375 Million

On Feb. 22, 2011, Foster City, Calif-based Gilead Sciences and Calistoga Pharmaceuticals announced Gilead’s acquisition of Calistoga for…

Read More Gilead Sciences acquired Calistoga Pharmaceuticals for $375 MillionContinue

Sanofi-aventis acquired Genzyme for $21 billion
Biotechnology | Diagnostics | Pharmaceutical | Therapeutics

Sanofi-aventis acquired Genzyme for $21 billion

On Feb. 15, 2011, Sanofi-aventis announced it would acquired Genzyme for $74 a share in cash or $21.1…

Read More Sanofi-aventis acquired Genzyme for $21 billionContinue

UCSF stem cell building was opened, a milestone for the pioneering program
Biotechnology | Diagnostics | Genomics | Stem Cell | Therapeutics

UCSF stem cell building was opened, a milestone for the pioneering program

On Feb. 9, 2011, the University of California, San Francisco (UCSF) celebrated the official opening of the Ray…

Read More UCSF stem cell building was opened, a milestone for the pioneering programContinue

Stanford Medicine researchers used skin cells from patients with a severe genetic heart defect to create human heart cells with the same genetic mutation
Biotechnology | Genomics | Therapeutics

Stanford Medicine researchers used skin cells from patients with a severe genetic heart defect to create human heart cells with the same genetic mutation

On Feb. 9, 2011, Stanford researchers used skin cells from patients with a severe genetic heart defect to…

Read More Stanford Medicine researchers used skin cells from patients with a severe genetic heart defect to create human heart cells with the same genetic mutationContinue

First international collaboration on Alzheimer’s disease genetics was launched
Biotechnology | Diagnostics | Disease | Neurology | Therapeutics

First international collaboration on Alzheimer’s disease genetics was launched

On Jan. 31, 2011, the first international collaboration on Alzheimer’s disease genetics was launched. The International Genomics of…

Read More First international collaboration on Alzheimer’s disease genetics was launchedContinue

Cardiac Science acquired by Opto Circuits of India for $55 million
Disease | Medical Device | Therapeutics

Cardiac Science acquired by Opto Circuits of India for $55 million

On Dec. 3, 2010, Banglore, India-based Opto Circuits announced completion of its merger with Bothell-based Cardiac Science Corp….

Read More Cardiac Science acquired by Opto Circuits of India for $55 millionContinue

Jane and Lee Seidman donated $42 million to University Hospitals for Cancer Center
Biotechnology | Diagnostics | Disease | Non-Profit Research | Oncology | Radiology | Therapeutics

Jane and Lee Seidman donated $42 million to University Hospitals for Cancer Center

On Nov. 30, 2010, Jane and Lee Seidman have donated $42 million to University Hospitals (UH) – the…

Read More Jane and Lee Seidman donated $42 million to University Hospitals for Cancer CenterContinue

Ozzy Osbourne’s Genome sequencing makes its move into pop culture
Biotechnology | Diagnostics | Genomics | Therapeutics

Ozzy Osbourne’s Genome sequencing makes its move into pop culture

On Oct. 25, 2010, The “Godfather of heavy metal,” “the Prince of Darkness,” the man who made himself…

Read More Ozzy Osbourne’s Genome sequencing makes its move into pop cultureContinue

ZymoGenetics was acquired by Bristol-Myers Squibb for $885 million
Biotechnology | Therapeutics

ZymoGenetics was acquired by Bristol-Myers Squibb for $885 million

On Oct. 12, 2010, Bristol-Myers Squibb Company announced it had completed its acquisition of ZymoGenetics. Bristol-Myers Squibb initiated…

Read More ZymoGenetics was acquired by Bristol-Myers Squibb for $885 millionContinue

Pacific Northwest Diabetes Research Institute appointed Jack Faris as CEO
Biotechnology | Genomics | Non-Profit Research | Therapeutics

Pacific Northwest Diabetes Research Institute appointed Jack Faris as CEO

On Sept. 15, 2010, Pacific Northwest Diabetes Research Institute appointed Jack Faris, Ph.D., as Chief Executive Officer. Previously,…

Read More Pacific Northwest Diabetes Research Institute appointed Jack Faris as CEOContinue

Driskill Foundation awarded $5 million to advance OHSU’s pioneering research in novel brain tumor treatment
Biotechnology | Diagnostics | Neurology | Non-Profit Research | Therapeutics

Driskill Foundation awarded $5 million to advance OHSU’s pioneering research in novel brain tumor treatment

On Aug. 25, 2010, Oregon Health & Science University (OHSU) announced a $5 million grant from the Walter…

Read More Driskill Foundation awarded $5 million to advance OHSU’s pioneering research in novel brain tumor treatmentContinue

OriGene Technologies aquired Blue Heron Biotechnology
Biotechnology | Therapeutics

OriGene Technologies aquired Blue Heron Biotechnology

On Aug. 12, 2010, OriGene Technologies based in Rockville, Maryland, announced the acquisition of Blue Heron Biotechnology, a…

Read More OriGene Technologies aquired Blue Heron BiotechnologyContinue

The Radiation Exposure Compensation Amendments of 1999 was signed into law
Biotechnology | Diagnostics | Disease | Life Science History | Oncology | Radiology | Therapeutics | U.S. Congress

The Radiation Exposure Compensation Amendments of 1999 was signed into law

On Jul. 7, 2010 the Radiation Exposure Compensation Amendments of 1999 (P.L. 106-245) was passed by the U.S….

Read More The Radiation Exposure Compensation Amendments of 1999 was signed into lawContinue

National PTSD Awareness Day was established
Biotechnology | Diagnostics | Disease | Neurology | Therapeutics | U.S. Congress

National PTSD Awareness Day was established

On Jun. 27, 2010, the U.S. Senate passed a resolution declaring June 27 as National PTSD Awareness Day….

Read More National PTSD Awareness Day was establishedContinue

The consolidated Dorris Neuroscience Center was dedicated at Scripps Research Institute
Biotechnology | Diagnostics | Neurology | Non-Profit Research | Therapeutics

The consolidated Dorris Neuroscience Center was dedicated at Scripps Research Institute

On May 25, 2010, the consolidated Dorris Neuroscience Center was dedicated at the Scripps Research Institute. The new…

Read More The consolidated Dorris Neuroscience Center was dedicated at Scripps Research InstituteContinue

The Lou Ruvo Center for Brain Health opened its doors
Biotechnology | Diagnostics | Neurology | Non-Profit Research | Therapeutics

The Lou Ruvo Center for Brain Health opened its doors

On May 21, 2010, The Lou Ruvo Center for Brain Health, also known as the Cleveland Clinic Lou…

Read More The Lou Ruvo Center for Brain Health opened its doorsContinue

1st U.S. patient walked out of the hospital without a human heart
Medical Device | Therapeutics

1st U.S. patient walked out of the hospital without a human heart

On May 3, 2010, Charles Okeke became the first U.S. patient to be discharged from the hospital without…

Read More 1st U.S. patient walked out of the hospital without a human heartContinue

PROVENGE was approved by the FDA
Biotechnology | FDA | Therapeutics

PROVENGE was approved by the FDA

On Apr. 29, 2010, the FDA approved sipuleucel-T (PROVENGE), made by the Dendreon Corp., an autologous cellular immunotherapy…

Read More PROVENGE was approved by the FDAContinue

Stanford researchers for the first time used a healthy person’s complete genome sequence to predict risk for dozens of diseases
Biotechnology | Diagnostics | Disease | Genomics | Non-Profit Research | Therapeutics

Stanford researchers for the first time used a healthy person’s complete genome sequence to predict risk for dozens of diseases

On Apr. 29, 2010, Stanford University of researchers announced they had have used a healthy person’s complete genome…

Read More Stanford researchers for the first time used a healthy person’s complete genome sequence to predict risk for dozens of diseasesContinue

Genentech opened its Hillsboro facility
Biotechnology | Diagnostics | Therapeutics

Genentech opened its Hillsboro facility

On Apr. 10, 2010, Genentech opened its $400 million manufacturing center in Hillsboro, Oregon. The 75-acre property campus…

Read More Genentech opened its Hillsboro facilityContinue

National Women and Girls HIV/AIDS Awareness Day was established
HIV | Infectious Disease | NIH | Non-Profit Research | Therapeutics | Women's Health

National Women and Girls HIV/AIDS Awareness Day was established

On Mar. 10, 2010, National Women and Girls HIV/AIDS Awareness Day (NWGHAAD) was established as a nationwide initiative…

Read More National Women and Girls HIV/AIDS Awareness Day was establishedContinue

Stanford scientists transformed mouse skin cells directly into functional nerve cells with the application of just three genes
Biotechnology | Non-Profit Research | Therapeutics

Stanford scientists transformed mouse skin cells directly into functional nerve cells with the application of just three genes

On Jan. 27, 2010, scientists at the Stanford University School of Medicine announced they had  succeeded in the…

Read More Stanford scientists transformed mouse skin cells directly into functional nerve cells with the application of just three genesContinue

St. Jude Children’s Hospital launched the Pediatric Cancer Genome Project
Biotechnology | Genomics | Non-Profit Research | Therapeutics

St. Jude Children’s Hospital launched the Pediatric Cancer Genome Project

On Jan. 25, 2010, St. Jude Children’s Research Hospital and Washington University School of Medicine launched a $65…

Read More St. Jude Children’s Hospital launched the Pediatric Cancer Genome ProjectContinue

The CDC responded to the 7.0 magnitude Haiti earthquake to prevent 7,000 deaths from cholera
CDC | Diagnostics | Infectious Disease | Medicine | Non-Profit Research | Therapeutics

The CDC responded to the 7.0 magnitude Haiti earthquake to prevent 7,000 deaths from cholera

On Jan. 12, 2010, the U.S. Centers for Disease Control and Prevention (CDC) responded to the 7.0 magnitude…

Read More The CDC responded to the 7.0 magnitude Haiti earthquake to prevent 7,000 deaths from choleraContinue

FDA Approves Tocilizumab for Treatment of Rheumatoid Arthritis
Biotechnology | FDA | Therapeutics

FDA Approves Tocilizumab for Treatment of Rheumatoid Arthritis

On Jan. 11, 2010, the U.S. Food and Drug Administration (FDA) approved Genentech’s tocilizumab (Actemra) for the treatment…

Read More FDA Approves Tocilizumab for Treatment of Rheumatoid ArthritisContinue

Page navigation

Previous PagePrevious 1 … 68 69 70 71 72 … 112 Next PageNext
  • Categories
  • Timeline
  • Agriculture
  • Artificial Intelligence
  • Biology
  • Biotechnology
  • Cardiovascular
  • Cartoons – Historical
  • Cartoons – Original
  • CDC
  • CDMO
  • Chemical
  • Clinical Research
  • Cloning
  • CMO
  • COVID-19
  • CRISPR
  • CRO
  • Cryogenic
  • Dentistry
  • Diagnostics
  • Disease
  • Energy
  • Environmental
  • EPA
  • FDA
  • Forestry
  • Genomics
  • HIV
  • Infectious Disease
  • Influenza
  • IRB
  • Life Science History
  • Marine Science
  • Materials
  • Measles
  • Medical Device
  • Medicine
  • Nanotechnology
  • Neurology
  • NIH
  • Non-Profit Research
  • Nutraceuticals
  • Oncology
  • Ophthalmogy
  • Organ Transplant
  • Orthopedic
  • Other
  • Pharmaceutical
  • Plague
  • Polio
  • Prehistory
  • Radiology
  • Rare Disease
  • Stem Cell
  • Therapeutics
  • U.S. Congress
  • Uncategorized
  • USDA
  • Vaccine
  • Veterinary
  • WHO
  • Women's Health
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
  • 1989
  • 1988
  • 1987
  • 1986
  • 1985
  • 1984
  • 1983
  • 1982
  • 1981
  • 1980
  • 1979
  • 1978
  • 1977
  • 1976
  • 1975
  • 1974
  • 1973
  • 1972
  • 1971
  • 1970
  • 1969
  • 1968
  • 1967
  • 1966
  • 1965
  • 1964
  • 1963
  • 1962
  • 1961
  • 1960
  • 1959
  • 1958
  • 1957
  • 1956
  • 1955
  • 1954
  • 1953
  • 1952
  • 1951
  • 1950
  • 1949
  • 1948
  • 1947
  • 1946
  • 1945
  • 1944
  • 1943
  • 1942
  • 1941
  • 1940
  • 1939
  • 1938
  • 1937
  • 1936
  • 1935
  • 1934
  • 1933
  • 1932
  • 1931
  • 1930
  • 1929
  • 1928
  • 1927
  • 1926
  • 1925
  • 1924
  • 1923
  • 1922
  • 1921
  • 1920
  • 1919
  • 1918
  • 1917
  • 1916
  • 1915
  • 1914
  • 1913
  • 1912
  • 1911
  • 1910
  • 1909
  • 1908
  • 1907
  • 1906
  • 1905
  • 1904
  • 1903
  • 1902
  • 1901
  • 1900
  • 1899
  • 1898
  • 1897
  • 1896
  • 1895
  • 1894
  • 1893
  • 1892
  • 1891
  • 1890
  • 1889
  • 1888
  • 1887
  • 1886
  • 1885
  • 1884
  • 1883
  • 1882
  • 1881
  • 1880
  • 1879
  • 1878
  • 1877
  • 1876
  • 1875
  • 1874
  • 1873
  • 1872
  • 1871
  • 1870
  • 1869
  • 1868
  • 1867
  • 1866
  • 1865
  • 1864
  • 1863
  • 1862
  • 1861
  • 1860
  • 1859
  • 1858
  • 1857
  • 1856
  • 1855
  • 1854
  • 1853
  • 1852
  • 1851
  • 1850
  • 1849
  • 1848
  • 1847
  • 1846
  • 1845
  • 1844
  • 1843
  • 1842
  • 1840
  • 1839
  • 1838
  • 1837
  • 1836
  • 1834
  • 1833
  • 1832
  • 1831
  • 1830
  • 1828
  • 1827
  • 1826
  • 1825
  • 1824
  • 1823
  • 1820
  • 1819
  • 1818
  • 1817
  • 1816
  • 1813
  • 1811
  • 1810
  • 1809
  • 1808
  • 1804
  • 1802
  • 1801
  • 1800
  • 1799
  • 1798
  • 1796
  • 1795
  • 1794
  • 1793
  • 1790
  • 1789
  • 1788
  • 1786
  • 1785
  • 1784
  • 1782
  • 1781
  • 1777
  • 1769
  • 1765
  • 1761
  • 1753
  • 1751
  • 1749
  • 1747
  • 1746
  • 1743
  • 1741
  • 1738
  • 1727
  • 1723
  • 1721
  • 1720
  • 1718
  • 1716
  • 1712
  • 1697
  • 1693
  • 1683
  • 1674
  • 1667
  • 1666
  • 1665
  • 1664
  • 1663
  • 1658
  • 1656
  • 1647
  • 1636
  • 1634
  • 1629
  • 1621
  • 1603
  • 1580
  • 1521
  • 1510
  • 1403
  • 1377
  • 1370
  • 1363
  • 1348
  • 1346
  • 1322
  • 1285
  • 1202
  • 1200
  • 1179
  • 1100
  • 1050
  • 541
  • 470
  • 1
Subscribe to E-History

Subscribe

* indicates required

LifeScienceHistory.com

LifeScienceHistory.com Where history is made daily, is a comprehensive companion of life science. Simply put, we dig history and we mine data.

More

  • About
  • Life Science Heroes

Advertising

  • Life Science Banner Advertising
  • Advertise Your Life Science Jobs

Legal

  • Privacy Policy
  • Terms of Use

© 2025 LifeScienceHistory.com by James Web Design

Facebook Instagram Linkedin
  • Home
  • Directory
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • News and History
  • Cartoons
  • Small World
  • Earth is a Rock
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
Search